>
  1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Sabby Management, Llc Buys Actinium Pharmaceuticals Inc, Ampio Pharmaceuticals Inc, China Jo-Jo Drugstores Inc, Sells Brainstorm Cell Therapeutics Inc, Odonate Therapeutics Inc, Loop Industries Inc

Upper Saddle River, NJ, based Investment company Sabby Management, Llc (Current Portfolio) buys Actinium Pharmaceuticals Inc, Ampio Pharmaceuticals Inc, China Jo-Jo Drugstores Inc, Genocea Biosciences Inc, Innovate Biopharmaceuticals Inc, sells Brainstorm Cell Therapeutics Inc, Odonate Therapeutics Inc, Loop Industries Inc, Biogen Inc, Oramed Pharmaceuticals Inc during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Sabby Management, Llc. As of 2019Q2, Sabby Management, Llc owns 56 stocks with a total value of $34 million. These are the details of the buys and sells.

For the details of SABBY MANAGEMENT, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/sabby+management%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of SABBY MANAGEMENT, LLC
  1. Odonate Therapeutics Inc (ODT) - 133,105 shares, 14.48% of the total portfolio. Shares reduced by 43.05%
  2. Actinium Pharmaceuticals Inc (ATNM) - 8,343,716 shares, 6.09% of the total portfolio. New Position
  3. Ampio Pharmaceuticals Inc (AMPE) - 5,265,265 shares, 6.05% of the total portfolio. New Position
  4. China Jo-Jo Drugstores Inc (CJJD) - 1,827,203 shares, 5.96% of the total portfolio. New Position
  5. Genocea Biosciences Inc (GNCA) - 494,175 shares, 5.74% of the total portfolio. New Position
New Purchase: Actinium Pharmaceuticals Inc (ATNM)

Sabby Management, Llc initiated holding in Actinium Pharmaceuticals Inc. The purchase prices were between $0.24 and $0.6, with an estimated average price of $0.33. The stock is now traded at around $0.22. The impact to a portfolio due to this purchase was 6.09%. The holding were 8,343,716 shares as of .

New Purchase: Ampio Pharmaceuticals Inc (AMPE)

Sabby Management, Llc initiated holding in Ampio Pharmaceuticals Inc. The purchase prices were between $0.39 and $0.7, with an estimated average price of $0.53. The stock is now traded at around $0.42. The impact to a portfolio due to this purchase was 6.05%. The holding were 5,265,265 shares as of .

New Purchase: China Jo-Jo Drugstores Inc (CJJD)

Sabby Management, Llc initiated holding in China Jo-Jo Drugstores Inc. The purchase prices were between $1.01 and $3.22, with an estimated average price of $1.41. The stock is now traded at around $1.07. The impact to a portfolio due to this purchase was 5.96%. The holding were 1,827,203 shares as of .

New Purchase: Genocea Biosciences Inc (GNCA)

Sabby Management, Llc initiated holding in Genocea Biosciences Inc. The purchase prices were between $3.47 and $6.71, with an estimated average price of $5.21. The stock is now traded at around $3.03. The impact to a portfolio due to this purchase was 5.74%. The holding were 494,175 shares as of .

New Purchase: Innovate Biopharmaceuticals Inc (INNT)

Sabby Management, Llc initiated holding in Innovate Biopharmaceuticals Inc. The purchase prices were between $1.07 and $2.04, with an estimated average price of $1.5. The stock is now traded at around $0.88. The impact to a portfolio due to this purchase was 4.59%. The holding were 1,336,248 shares as of .

New Purchase: Diffusion Pharmaceuticals Inc (DFFN)

Sabby Management, Llc initiated holding in Diffusion Pharmaceuticals Inc. The purchase prices were between $2.76 and $5.9, with an estimated average price of $3.59. The stock is now traded at around $2.04. The impact to a portfolio due to this purchase was 3.96%. The holding were 468,620 shares as of .

Added: Vaxart Inc (VXRT)

Sabby Management, Llc added to a holding in Vaxart Inc by 367.33%. The purchase prices were between $0.63 and $2.04, with an estimated average price of $0.83. The stock is now traded at around $0.66. The impact to a portfolio due to this purchase was 1.44%. The holding were 920,647 shares as of .

Added: Oragenics Inc (OGEN)

Sabby Management, Llc added to a holding in Oragenics Inc by 146.60%. The purchase prices were between $0.46 and $0.6, with an estimated average price of $0.51. The stock is now traded at around $0.40. The impact to a portfolio due to this purchase was 1.09%. The holding were 1,259,333 shares as of .

Added: NeuroMetrix Inc (NURO)

Sabby Management, Llc added to a holding in NeuroMetrix Inc by 163.24%. The purchase prices were between $0.4 and $1.08, with an estimated average price of $0.73. The stock is now traded at around $0.35. The impact to a portfolio due to this purchase was 0.61%. The holding were 809,482 shares as of .

Added: Superconductor Technologies Inc (SCON)

Sabby Management, Llc added to a holding in Superconductor Technologies Inc by 78.95%. The purchase prices were between $0.71 and $1.71, with an estimated average price of $1.23. The stock is now traded at around $0.74. The impact to a portfolio due to this purchase was 0.5%. The holding were 467,900 shares as of .

Added: Synthetic Biologics Inc (SYN)

Sabby Management, Llc added to a holding in Synthetic Biologics Inc by 31.95%. The purchase prices were between $0.49 and $0.66, with an estimated average price of $0.58. The stock is now traded at around $0.43. The impact to a portfolio due to this purchase was 0.36%. The holding were 903,741 shares as of .

Added: Sophiris Bio Inc (SPHS)

Sabby Management, Llc added to a holding in Sophiris Bio Inc by 56.60%. The purchase prices were between $0.71 and $1.1, with an estimated average price of $0.88. The stock is now traded at around $1.00. The impact to a portfolio due to this purchase was 0.05%. The holding were 52,685 shares as of .

Sold Out: Loop Industries Inc (LOOP)

Sabby Management, Llc sold out a holding in Loop Industries Inc. The sale prices were between $6.63 and $9.99, with an estimated average price of $7.78.

Sold Out: Biogen Inc (BIIB)

Sabby Management, Llc sold out a holding in Biogen Inc. The sale prices were between $219.29 and $241.72, with an estimated average price of $230.78.

Sold Out: FibroGen Inc (FGEN)

Sabby Management, Llc sold out a holding in FibroGen Inc. The sale prices were between $35.13 and $55.53, with an estimated average price of $43.71.

Sold Out: AquaBounty Technologies Inc (AQB)

Sabby Management, Llc sold out a holding in AquaBounty Technologies Inc. The sale prices were between $1.96 and $3.21, with an estimated average price of $2.35.

Sold Out: Novavax Inc (NVAX)

Sabby Management, Llc sold out a holding in Novavax Inc. The sale prices were between $4.93 and $12.24, with an estimated average price of $7.88.

Sold Out: Taronis Technologies Inc (9MGM)

Sabby Management, Llc sold out a holding in Taronis Technologies Inc. The sale prices were between $0.14 and $0.83, with an estimated average price of $0.45.



Here is the complete portfolio of SABBY MANAGEMENT, LLC. Also check out:

1. SABBY MANAGEMENT, LLC's Undervalued Stocks
2. SABBY MANAGEMENT, LLC's Top Growth Companies, and
3. SABBY MANAGEMENT, LLC's High Yield stocks
4. Stocks that SABBY MANAGEMENT, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
wigbertHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)